Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC Article Swipe
Caicun Zhou
,
Silvia Novello
,
Pilar Garrido
,
Christophe Dooms
,
Jorge Alatorre-Alexander
,
Niels Reinmuth
,
Gill Worthy
,
Kim Cocks
,
Justin N. Williams
,
Hongmei Han
,
Minji K. Uh
,
Nalin Payakachat
,
Adrienne M. Gilligan
,
Koichi Goto
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.jtocrr.2025.100814
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.jtocrr.2025.100814
These PROs, combined with the established efficacy and safety profile of selpercatinib, further support the use of first-line selpercatinib as a standard of care and highlight the importance of early and comprehensive genomic testing in patients with RET fusion-positive NSCLC.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.jtocrr.2025.100814
- OA Status
- gold
- References
- 21
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4407739400
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4407739400Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.jtocrr.2025.100814Digital Object Identifier
- Title
-
Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLCWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-19Full publication date if available
- Authors
-
Caicun Zhou, Silvia Novello, Pilar Garrido, Christophe Dooms, Jorge Alatorre-Alexander, Niels Reinmuth, Gill Worthy, Kim Cocks, Justin N. Williams, Hongmei Han, Minji K. Uh, Nalin Payakachat, Adrienne M. Gilligan, Koichi GotoList of authors in order
- Landing page
-
https://doi.org/10.1016/j.jtocrr.2025.100814Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.jtocrr.2025.100814Direct OA link when available
- Concepts
-
Pembrolizumab, Medicine, Chemotherapy, Oncology, Internal medicine, Cancer, ImmunotherapyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
21Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4407739400 |
|---|---|
| doi | https://doi.org/10.1016/j.jtocrr.2025.100814 |
| ids.doi | https://doi.org/10.1016/j.jtocrr.2025.100814 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40567260 |
| ids.openalex | https://openalex.org/W4407739400 |
| fwci | 0.0 |
| type | article |
| title | Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC |
| biblio.issue | 7 |
| biblio.volume | 6 |
| biblio.last_page | 100814 |
| biblio.first_page | 100814 |
| grants[0].funder | https://openalex.org/F4320307758 |
| grants[0].award_id | |
| grants[0].funder_display_name | Eli Lilly and Company |
| grants[1].funder | https://openalex.org/F4320320300 |
| grants[1].award_id | |
| grants[1].funder_display_name | European Commission |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T11067 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9998000264167786 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Colorectal Cancer Treatments and Studies |
| topics[2].id | https://openalex.org/T10417 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9997000098228455 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Lung Cancer Treatments and Mutations |
| funders[0].id | https://openalex.org/F4320307758 |
| funders[0].ror | https://ror.org/01qat3289 |
| funders[0].display_name | Eli Lilly and Company |
| funders[1].id | https://openalex.org/F4320320300 |
| funders[1].ror | https://ror.org/00k4n6c32 |
| funders[1].display_name | European Commission |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | USD |
| apc_list.value_usd | 2000 |
| apc_paid.value | 2000 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2000 |
| concepts[0].id | https://openalex.org/C2780057760 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7499471306800842 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q13896859 |
| concepts[0].display_name | Pembrolizumab |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6468127965927124 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2776694085 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5904238820075989 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[2].display_name | Chemotherapy |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.48477619886398315 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.42690175771713257 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C121608353 |
| concepts[5].level | 2 |
| concepts[5].score | 0.12076309323310852 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[5].display_name | Cancer |
| concepts[6].id | https://openalex.org/C2777701055 |
| concepts[6].level | 3 |
| concepts[6].score | 0.06932333111763 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[6].display_name | Immunotherapy |
| keywords[0].id | https://openalex.org/keywords/pembrolizumab |
| keywords[0].score | 0.7499471306800842 |
| keywords[0].display_name | Pembrolizumab |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6468127965927124 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/chemotherapy |
| keywords[2].score | 0.5904238820075989 |
| keywords[2].display_name | Chemotherapy |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.48477619886398315 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.42690175771713257 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/cancer |
| keywords[5].score | 0.12076309323310852 |
| keywords[5].display_name | Cancer |
| keywords[6].id | https://openalex.org/keywords/immunotherapy |
| keywords[6].score | 0.06932333111763 |
| keywords[6].display_name | Immunotherapy |
| language | en |
| locations[0].id | doi:10.1016/j.jtocrr.2025.100814 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210220242 |
| locations[0].source.issn | 2666-3643 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2666-3643 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | JTO Clinical and Research Reports |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JTO Clinical and Research Reports |
| locations[0].landing_page_url | https://doi.org/10.1016/j.jtocrr.2025.100814 |
| locations[1].id | pmid:40567260 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | JTO clinical and research reports |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40567260 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12192610 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | JTO Clin Res Rep |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12192610 |
| locations[3].id | pmh:oai:doaj.org/article:5bf3ffcb0c6c4836b4103e78cd238435 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | JTO Clinical and Research Reports, Vol 6, Iss 7, Pp 100814- (2025) |
| locations[3].landing_page_url | https://doaj.org/article/5bf3ffcb0c6c4836b4103e78cd238435 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5109585647 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Caicun Zhou |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I116953780, https://openalex.org/I4210127126 |
| authorships[0].affiliations[0].raw_affiliation_string | Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. |
| authorships[0].institutions[0].id | https://openalex.org/I4210127126 |
| authorships[0].institutions[0].ror | https://ror.org/033nbnf69 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210127126 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Shanghai Pulmonary Hospital |
| authorships[0].institutions[1].id | https://openalex.org/I116953780 |
| authorships[0].institutions[1].ror | https://ror.org/03rc6as71 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I116953780 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Tongji University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Caicun Zhou |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. |
| authorships[1].author.id | https://openalex.org/A5084937082 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Silvia Novello |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210155833, https://openalex.org/I55143463 |
| authorships[1].affiliations[0].raw_affiliation_string | University of Turin, AOU San Luigi-Orbassano, Italy. |
| authorships[1].institutions[0].id | https://openalex.org/I4210155833 |
| authorships[1].institutions[0].ror | https://ror.org/04nzv4p86 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210155833 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | Ospedale San Luigi Gonzaga |
| authorships[1].institutions[1].id | https://openalex.org/I55143463 |
| authorships[1].institutions[1].ror | https://ror.org/048tbm396 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I55143463 |
| authorships[1].institutions[1].country_code | IT |
| authorships[1].institutions[1].display_name | University of Turin |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Silvia Novello |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University of Turin, AOU San Luigi-Orbassano, Italy. |
| authorships[2].author.id | https://openalex.org/A5050766137 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5899-6125 |
| authorships[2].author.display_name | Pilar Garrido |
| authorships[2].affiliations[0].raw_affiliation_string | Ramón y Cajal Hospital, Madrid, Spain. |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Pilar Garrido |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Ramón y Cajal Hospital, Madrid, Spain. |
| authorships[3].author.id | https://openalex.org/A5028699633 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7324-7977 |
| authorships[3].author.display_name | Christophe Dooms |
| authorships[3].countries | BE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2800231306 |
| authorships[3].affiliations[0].raw_affiliation_string | UZ Leuven, University Hospitals Leuven, Leuven, Belgium. |
| authorships[3].institutions[0].id | https://openalex.org/I2800231306 |
| authorships[3].institutions[0].ror | https://ror.org/0424bsv16 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2800231306 |
| authorships[3].institutions[0].country_code | BE |
| authorships[3].institutions[0].display_name | Universitair Ziekenhuis Leuven |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Christophe Dooms |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | UZ Leuven, University Hospitals Leuven, Leuven, Belgium. |
| authorships[4].author.id | https://openalex.org/A5017066894 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0080-6410 |
| authorships[4].author.display_name | Jorge Alatorre-Alexander |
| authorships[4].countries | MX |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210102695 |
| authorships[4].affiliations[0].raw_affiliation_string | Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico. |
| authorships[4].institutions[0].id | https://openalex.org/I4210102695 |
| authorships[4].institutions[0].ror | https://ror.org/017fh2655 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210095685, https://openalex.org/I4210102695 |
| authorships[4].institutions[0].country_code | MX |
| authorships[4].institutions[0].display_name | Instituto Nacional de Enfermedades Respiratorias |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jorge Alatorre-Alexander |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico. |
| authorships[5].author.id | https://openalex.org/A5072753291 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7369-4512 |
| authorships[5].author.display_name | Niels Reinmuth |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210125421 |
| authorships[5].affiliations[0].raw_affiliation_string | Asklepios Lungenklinik, München, Germany. |
| authorships[5].institutions[0].id | https://openalex.org/I4210125421 |
| authorships[5].institutions[0].ror | https://ror.org/02v4fpg03 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210125421 |
| authorships[5].institutions[0].country_code | DE |
| authorships[5].institutions[0].display_name | Asklepios Fachkliniken München-Gauting |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Niels Reinmuth |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Asklepios Lungenklinik, München, Germany. |
| authorships[6].author.id | https://openalex.org/A5040279436 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Gill Worthy |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210091464 |
| authorships[6].affiliations[0].raw_affiliation_string | Adelphi Values, Bollington, Cheshire, United Kingdom. |
| authorships[6].institutions[0].id | https://openalex.org/I4210091464 |
| authorships[6].institutions[0].ror | https://ror.org/00egpfv87 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210091464 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | Adelphi Group (United Kingdom) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Gill Worthy |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Adelphi Values, Bollington, Cheshire, United Kingdom. |
| authorships[7].author.id | https://openalex.org/A5011400814 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2595-708X |
| authorships[7].author.display_name | Kim Cocks |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210091464 |
| authorships[7].affiliations[0].raw_affiliation_string | Adelphi Values, Bollington, Cheshire, United Kingdom. |
| authorships[7].institutions[0].id | https://openalex.org/I4210091464 |
| authorships[7].institutions[0].ror | https://ror.org/00egpfv87 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210091464 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | Adelphi Group (United Kingdom) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Kim Cocks |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Adelphi Values, Bollington, Cheshire, United Kingdom. |
| authorships[8].author.id | https://openalex.org/A5022745113 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-2341-2596 |
| authorships[8].author.display_name | Justin N. Williams |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I168537998 |
| authorships[8].affiliations[0].raw_affiliation_string | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[8].institutions[0].id | https://openalex.org/I168537998 |
| authorships[8].institutions[0].ror | https://ror.org/01qat3289 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I168537998 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Eli Lilly (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Justin Williams |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[9].author.id | https://openalex.org/A5102940217 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0494-6624 |
| authorships[9].author.display_name | Hongmei Han |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I168537998 |
| authorships[9].affiliations[0].raw_affiliation_string | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[9].institutions[0].id | https://openalex.org/I168537998 |
| authorships[9].institutions[0].ror | https://ror.org/01qat3289 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I168537998 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Eli Lilly (United States) |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Hongmei Han |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[10].author.id | https://openalex.org/A5049983930 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Minji K. Uh |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I168537998 |
| authorships[10].affiliations[0].raw_affiliation_string | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[10].institutions[0].id | https://openalex.org/I168537998 |
| authorships[10].institutions[0].ror | https://ror.org/01qat3289 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I168537998 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Eli Lilly (United States) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Minji K Uh |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[11].author.id | https://openalex.org/A5037802250 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-9526-5356 |
| authorships[11].author.display_name | Nalin Payakachat |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I168537998 |
| authorships[11].affiliations[0].raw_affiliation_string | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[11].institutions[0].id | https://openalex.org/I168537998 |
| authorships[11].institutions[0].ror | https://ror.org/01qat3289 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I168537998 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Eli Lilly (United States) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Nalin Payakachat |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[12].author.id | https://openalex.org/A5103532826 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Adrienne M. Gilligan |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I168537998 |
| authorships[12].affiliations[0].raw_affiliation_string | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[12].institutions[0].id | https://openalex.org/I168537998 |
| authorships[12].institutions[0].ror | https://ror.org/01qat3289 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I168537998 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Eli Lilly (United States) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Adrienne M Gilligan |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Eli Lilly and Company, Indianapolis, Indiana. |
| authorships[13].author.id | https://openalex.org/A5111936421 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Koichi Goto |
| authorships[13].countries | JP |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210145079 |
| authorships[13].affiliations[0].raw_affiliation_string | National Cancer Center Hospital East, Kashiwa, Japan. |
| authorships[13].institutions[0].id | https://openalex.org/I4210145079 |
| authorships[13].institutions[0].ror | https://ror.org/03rm3gk43 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210145079 |
| authorships[13].institutions[0].country_code | JP |
| authorships[13].institutions[0].display_name | National Cancer Center Hospital East |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Koichi Goto |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | National Cancer Center Hospital East, Kashiwa, Japan. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.jtocrr.2025.100814 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-02-20T00:00:00 |
| display_name | Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W3180083804, https://openalex.org/W2796582438 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1016/j.jtocrr.2025.100814 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210220242 |
| best_oa_location.source.issn | 2666-3643 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2666-3643 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | JTO Clinical and Research Reports |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | JTO Clinical and Research Reports |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.jtocrr.2025.100814 |
| primary_location.id | doi:10.1016/j.jtocrr.2025.100814 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210220242 |
| primary_location.source.issn | 2666-3643 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2666-3643 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | JTO Clinical and Research Reports |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JTO Clinical and Research Reports |
| primary_location.landing_page_url | https://doi.org/10.1016/j.jtocrr.2025.100814 |
| publication_date | 2025-02-19 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4296460186, https://openalex.org/W3080978633, https://openalex.org/W4295882695, https://openalex.org/W4387844786, https://openalex.org/W4291899361, https://openalex.org/W2034204383, https://openalex.org/W2333674118, https://openalex.org/W3197371806, https://openalex.org/W4406747829, https://openalex.org/W1913022536, https://openalex.org/W6809054304, https://openalex.org/W2167571044, https://openalex.org/W4280551559, https://openalex.org/W2769746786, https://openalex.org/W4399706687, https://openalex.org/W4399706526, https://openalex.org/W2018304470, https://openalex.org/W4221006949, https://openalex.org/W1982946927, https://openalex.org/W2890591279, https://openalex.org/W4213163701 |
| referenced_works_count | 21 |
| abstract_inverted_index.a | 20 |
| abstract_inverted_index.as | 19 |
| abstract_inverted_index.in | 34 |
| abstract_inverted_index.of | 10, 16, 22, 28 |
| abstract_inverted_index.and | 7, 24, 30 |
| abstract_inverted_index.the | 4, 14, 26 |
| abstract_inverted_index.use | 15 |
| abstract_inverted_index.care | 23 |
| abstract_inverted_index.with | 3, 36 |
| abstract_inverted_index.PROs, | 1 |
| abstract_inverted_index.These | 0 |
| abstract_inverted_index.early | 29 |
| abstract_inverted_index.NSCLC. | 39 |
| abstract_inverted_index.safety | 8 |
| abstract_inverted_index.further | 12 |
| abstract_inverted_index.genomic | 32 |
| abstract_inverted_index.profile | 9 |
| abstract_inverted_index.support | 13 |
| abstract_inverted_index.testing | 33 |
| abstract_inverted_index.combined | 2 |
| abstract_inverted_index.efficacy | 6 |
| abstract_inverted_index.patients | 35 |
| abstract_inverted_index.standard | 21 |
| abstract_inverted_index.highlight | 25 |
| abstract_inverted_index.<i>RET</i> | 37 |
| abstract_inverted_index.first-line | 17 |
| abstract_inverted_index.importance | 27 |
| abstract_inverted_index.established | 5 |
| abstract_inverted_index.comprehensive | 31 |
| abstract_inverted_index.selpercatinib | 18 |
| abstract_inverted_index.selpercatinib, | 11 |
| abstract_inverted_index.fusion-positive | 38 |
| cited_by_percentile_year | |
| countries_distinct_count | 8 |
| institutions_distinct_count | 14 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5699999928474426 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.06862513 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |